Acquirer(s)
- Dentsply (Australia) Pty Ltd
Target(s)
- Astrazeneca Pty Ltd (Astra Zeneca)
Summary
Acquisition by subsidiary of Dentsply International of certain local assets of Astra Zeneca PlcMarket definition
dental local injectable anaestheticsCompetition analysis
In September 2002 the Commission decided that the acquisition and subsequent changes to distribution arrangements for AstraZeneca products were unlikely to substantially lessen competition in the national market for the supply of dental local injectable anaesthetics due to import competition, the surrender of distribution rights for Septodont, and the potential for new entry.Merger type
Horizontal
Guidelines thresholds
Unknown
Imports above 10%
Unknown
Initiation
Complaint
ANZSIC code
4796